Log in to save to my catalogue

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_220b22c2b2924f9d9dbd7a4b216ca1d5

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

About this item

Full title

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

Publisher

Basel: MDPI AG

Journal title

Vaccines (Basel), 2022-09, Vol.10 (9), p.1458

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

The durability of immune responses after COVID-19 vaccination will drive long-term vaccine effectiveness across settings and may differ by vaccine type. To determine durability of protection of COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) following primary vaccination in the United States, a matched case-control study was conducted in t...

Alternative Titles

Full title

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_220b22c2b2924f9d9dbd7a4b216ca1d5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_220b22c2b2924f9d9dbd7a4b216ca1d5

Other Identifiers

ISSN

2076-393X

E-ISSN

2076-393X

DOI

10.3390/vaccines10091458

How to access this item